Loading compound...

Small molecule cancer research drug

Tozasertib is an experimental small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat various types of cancer, including certain leukemias and lung cancer.

How it worksTozasertib is a small molecule designed to act on specific biological targets to help fight cancer cells.

Used for
LeukemiaNon-small cell lung carcinomaCancerMyelodysplastic syndromeAcute lymphoblastic leukemiaChronic myelogenous leukemiaLymphoid leukemiaColorectal carcinoma
Conditions
LeukemiaNon-small cell lung carcinomaMyelodysplastic syndromeAcute lymphoblastic leukemiaChronic myelogenous leukemiaLymphoid leukemiaColorectal carcinoma
Class
Small moleculeSmall molecule cancer research drugHematologic

How to take

This drug is in the research phase (max phase 2) and is not yet FDA-approved for general use. Information regarding specific dosing and administration is not available in the provided data.

Talk to your doctor

Questions to ask

  • ·Is Tozasertib part of any clinical trials I might qualify for?
  • ·How does Tozasertib differ from my current cancer treatments?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.